002589.SZ

Realcan Pharmaceutical Group Co., Ltd. [002589.SZ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

002589.SZ Stock Summary

Top 10 Correlated Stocks

002589.SZ

In the News

002589.SZ Financial details

Company Rating
-
Market Cap
4.16B
Income
-1.86B
Revenue
7.52B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
5.12K
Optionable
No
Shortable
Yes
Earnings
30 Apr 2024
P/E
-2.5
Forward P/E
-
PEG
0.04
P/S
0.62
P/B
0.85
P/C
-
P/FCF
-2.59
Quick Ratio
0.98
Current Ratio
1.05
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.26
EPS next Y
-
EPS next Q
-
EPS this Y
-553.85%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-18.35%
Revenue Q/Q
0.91%
EPS Q/Q
-220.63%
-
-
-
-
SMA20
-25%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-11%
ROE
-34%
ROC
-0.31%
Gross Margin
9%
Oper. Margin
-25%
Profit Margin
-25%
Payout
-26%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.05-3.97
52W High
+31%
52W Low
+96.5%
RSI
66
Rel Volume
16.15
Avg Volume
26.99M
Volume
435.81M
Perf Week
19.45%
Perf Month
24.37%
Perf Quarter
29.28%
Perf Half Y
29.28%
-
-
-
-
Beta
0.536
-
-
Volatility
0.24%, 0.34%
Prev Close
2.61%
Price
3.93
Change
12.29%

Something similar

Top by Market Cap
DHR-PB
MSFT
CMC.DE
VFINX
M&M.NS
Same Sector
SECARE.ST
BLPH
VIVE
RCEL
TTALO.HE
Top Correlated Stocks
CDXS
HCBC
IDEA
002679.SZ
3558.TWO
Similar Market Cap
1387.HK
SWON.SW
0086.HK
IBCS.DE
0HR3.L

Company Profile

Healthcare Medical - Distribution
  • Volume Average 26.99M
  • Market Capitalization 4.16B
  • Employee 5.12K
  • CEO Ms. Renhua Zhang
  • Headquarters Yantai,CN
  • IPO Date 2011-06-10
  • Website https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institution worldwide. It sells drugs, vaccines, and medical devices. The company also provides medical logistics services; third-party logistics services; disinfection and sterilization; and lease, and hospital logistics services for medical institutions. It serves drug distribution, academic services, medical diagnosis, financial technology, traditional Chinese medicine, digital medical care, professional logistics, and comprehensive equipment. The company was formerly known as Realcan Pharmaceutical Co., Ltd. and changed its name to Realcan Pharmaceutical Group Co., Ltd. in December 2018. Realcan Pharmaceutical Group Co., Ltd. was founded in 2004 and is based in Yantai, China.